Showing results (6231-6240 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|February 23, 2005
Discovery strategies in a BioPharmaceutical startup: maximising your chances of success using computational filtersA Jennings, M TennantCurrent Pharmaceutical Design|February 23, 2005
The design of cationic lipids for gene deliveryB Martin, M Sainlos, A Aissaoui, et al.Current Pharmaceutical Design|February 23, 2005
Thalidomide as an immunotherapeutic agent: the effects on neutrophil-mediated inflammationKozo Yasui, Norimoto Kobayashi, Takashi Yamazaki, et al.Current Pharmaceutical Design|April 14, 2004
Heparins and heparinoids: occurrence, structure and mechanism of antithrombotic and hemorrhagic activitiesHelena B Nader, Carla C Lopes, Hugo A O Rocha, et al.Current Pharmaceutical Design|April 14, 2004
Antiangiogenic therapy in hematologic malignanciesT M Moehler, J Hillengass, H Goldschmidt, et al.Current Pharmaceutical Design|February 18, 2004
Local drug delivery using coated stents: new developments and future perspectivesKengo Tanabe, Evelyn Regar, Chi Hang Lee, et al.Current Pharmaceutical Design|February 18, 2004
Insights into early and rapid effects of statin therapy after coronary interventionsDirk H WalterCurrent Pharmaceutical Design|February 18, 2004
GP IIb/IIIa blockade in elective percutaneous coronary interventionJ P Dery, R A Harrington, J E TchengCurrent Pharmaceutical Design|February 18, 2004
Clinical pharmacology of novel selective COX-2 inhibitorsS Tacconelli, M L Capone, P PatrignaniCurrent Pharmaceutical Design|February 18, 2004
Possibility of non-immunosuppressive immunophilin ligands as potential therapeutic agents for Parkinson's diseaseK Tanaka, N OgawaPageof 1,008